FdaApplication
BLA 761184
Identifiers
- fda_app_no: BLA761184
Properties
| Property | Value |
|---|---|
| applicant_name | Pfizer Ireland Pharmaceuticals Unlimited Company |
| application_type | BLA |
| approval_date | 2023-06-27 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NGENLA | SOMATROGON-GHLA | 60MG/1.2ML (50MG/ML) | Injection |
| NGENLA | SOMATROGON-GHLA | 24MG/1.2ML (20MG/ML) | Injection |
2 products